SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-049683
Filing Date
2019-09-16
Accepted
2019-09-16 17:28:24
Documents
1
Period of Report
2019-09-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3536
  Complete submission text file 0001209191-19-049683.txt   4909
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address
KALAJIAN TONY T (Reporting) CIK: 0001786237 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 191095469